MGX Q1 2026 Earnings EPS Miss Reflects Increased RD Spending Amid Pipeline Progress IPM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter NAGE Q1 2026 Earnings Modest EPS Beat Amid Limited Revenue Disclosure ADXN Q1 2024 Earnings Biotech Reports Net Loss Amid Clinical Pipeline Progress DDL Q4 2025 Earnings Profitability Milestone Despite Mixed Market Signals BFH Q1 2026 Earnings Beats Estimates with EPS Surprise of 3383